ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

RVMD Revolution Medicines Inc

39.445
0.255 (0.65%)
最終更新日: 02:45:39
15分遅延
名称 銘柄コード 市場 種別
Revolution Medicines Inc RVMD NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.255 0.65% 39.445 02:45:39
始値 安値 高値 終値 前日終値
40.00 39.10 40.20 39.19
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0205:05GLOBERevolution Medicines to Report Financial Results for First..
2024/4/1004:34GLOBERevolution Medicines Announces Publication on the Discovery..
2024/4/0900:36GLOBERevolution Medicines Announces Publications on the Discovery..
2024/4/0505:05GLOBERevolution Medicines to Participate in Upcoming Investor..
2024/3/2905:05GLOBERevolution Medicines to Deliver Multiple Presentations at..
2024/3/0606:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0507:23EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2024/2/2707:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2706:05GLOBERevolution Medicines Reports Fourth Quarter and Full Year..
2024/2/2706:04EDGAR2Form 8-K - Current report
2024/2/2106:05GLOBERevolution Medicines to Report Financial Results for Fourth..
2024/2/1007:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0206:05GLOBERevolution Medicines to Participate in Upcoming Investor..
2024/1/2506:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2306:18EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1004:15EDGAR2Form 8-K - Current report
2024/1/0421:00GLOBERevolution Medicines to Present at 42nd Annual J.P...
2023/12/2107:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2107:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1508:22EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1507:48EDGAR2Form 144 - Report of proposed sale of securities
2023/11/2108:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2106:14EDGAR2Form 144 - Report of proposed sale of securities
2023/11/1704:58EDGAR2Form CERT - Certification by an exchange approving..
2023/11/1606:04EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
2023/11/1510:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1510:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1510:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/11/0923:20EDGAR2Form 8-K - Current report
2023/11/0923:10GLOBERevolution Medicines Completes Acquisition of EQRx
2023/11/0901:30GLOBERevolution Medicines and EQRx Stockholders Approve EQRx..
2023/11/0706:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0706:05GLOBERevolution Medicines Reports Third Quarter 2023 Financial..
2023/11/0706:05EDGAR2Form 8-K - Current report
2023/11/0120:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/11/0120:11EDGAR2Form 425 - Prospectuses and communications, business..
2023/11/0120:08EDGAR2Form 8-K - Current report
2023/11/0120:00GLOBELeading Independent Proxy Advisory Firms ISS and Glass Lewis..
2023/11/0105:15GLOBERevolution Medicines to Report Financial Results for Third..
2023/10/2407:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2319:13EDGAR2Form 425 - Prospectuses and communications, business..
2023/10/2319:11EDGAR2Form 8-K - Current report
2023/10/2215:30GLOBERevolution Medicines Presents Promising Clinical Activity..
2023/10/1400:54EDGAR2Form 8-K - Current report
2023/10/1400:50GLOBERevolution Medicines Presents Encouraging Clinical Data for..
2023/10/0505:05GLOBERevolution Medicines to Present New Clinical Data at Major..
2023/10/0305:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/3005:19EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..

最近閲覧した銘柄

Delayed Upgrade Clock